STI Co., Ltd.

KOSDAQ:A039440 Rapport sur les actions

Capitalisation boursière : ₩385.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

STI Croissance future

Future contrôle des critères 6/6

STI devrait augmenter ses bénéfices et son chiffre d'affaires de 39.2% et de 25.3% par an respectivement. Le BPA devrait croître de de 38.1% par an. Le rendement des capitaux propres devrait être 23.3% dans 3 ans.

Informations clés

48.5%

Taux de croissance des bénéfices

47.2%

Taux de croissance du BPA

Semiconductor croissance des bénéfices47.6%
Taux de croissance des recettes31.5%
Rendement futur des capitaux propres23.9%
Couverture par les analystes

Low

Dernière mise à jour16 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

STI Co., Ltd. (KOSDAQ:039440) Stocks Pounded By 27% But Not Lagging Market On Growth Or Pricing

Jul 25
STI Co., Ltd. (KOSDAQ:039440) Stocks Pounded By 27% But Not Lagging Market On Growth Or Pricing

Is It Too Late To Consider Buying STI Co., Ltd. (KOSDAQ:039440)?

May 21
Is It Too Late To Consider Buying STI Co., Ltd. (KOSDAQ:039440)?

Estimating The Intrinsic Value Of STI Co., Ltd. (KOSDAQ:039440)

Apr 16
Estimating The Intrinsic Value Of STI Co., Ltd. (KOSDAQ:039440)

STI's (KOSDAQ:039440) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 28
STI's (KOSDAQ:039440) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Why Investors Shouldn't Be Surprised By STI Co., Ltd.'s (KOSDAQ:039440) 27% Share Price Surge

Feb 26
Why Investors Shouldn't Be Surprised By STI Co., Ltd.'s (KOSDAQ:039440) 27% Share Price Surge

Does STI (KOSDAQ:039440) Have A Healthy Balance Sheet?

May 03
Does STI (KOSDAQ:039440) Have A Healthy Balance Sheet?

Is STI Co., Ltd. (KOSDAQ:039440) An Attractive Dividend Stock?

Apr 14
Is STI Co., Ltd. (KOSDAQ:039440) An Attractive Dividend Stock?

Are STI Co., Ltd. (KOSDAQ:039440) Investors Paying Above The Intrinsic Value?

Apr 01
Are STI Co., Ltd. (KOSDAQ:039440) Investors Paying Above The Intrinsic Value?

What Is STI Co., Ltd.'s (KOSDAQ:039440) Share Price Doing?

Mar 19
What Is STI Co., Ltd.'s (KOSDAQ:039440) Share Price Doing?

Should You Be Impressed By STI's (KOSDAQ:039440) Returns on Capital?

Mar 04
Should You Be Impressed By STI's (KOSDAQ:039440) Returns on Capital?

STI (KOSDAQ:039440) Has Gifted Shareholders With A Fantastic 178% Total Return On Their Investment

Feb 17
STI (KOSDAQ:039440) Has Gifted Shareholders With A Fantastic 178% Total Return On Their Investment

Here's Why STI (KOSDAQ:039440) Has A Meaningful Debt Burden

Feb 02
Here's Why STI (KOSDAQ:039440) Has A Meaningful Debt Burden

Is STI Co., Ltd.'s (KOSDAQ:039440) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Jan 18
Is STI Co., Ltd.'s (KOSDAQ:039440) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Read This Before Buying STI Co., Ltd. (KOSDAQ:039440) For Its Dividend

Jan 03
Read This Before Buying STI Co., Ltd. (KOSDAQ:039440) For Its Dividend

Is There Now An Opportunity In STI Co., Ltd. (KOSDAQ:039440)?

Dec 10
Is There Now An Opportunity In STI Co., Ltd. (KOSDAQ:039440)?

Should We Be Excited About The Trends Of Returns At STI (KOSDAQ:039440)?

Nov 25
Should We Be Excited About The Trends Of Returns At STI (KOSDAQ:039440)?

Prévisions de croissance des bénéfices et des revenus

KOSDAQ:A039440 - Estimations futures des analystes et données financières antérieures (KRW Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026654,86778,03383,80072,4333
12/31/2025642,70083,40068,50070,8333
12/31/2024369,20030,50018,40015,5002
6/30/2024297,56120,426-23514,373N/A
3/31/2024299,65719,2884567,933N/A
12/31/2023319,46324,07625,26329,196N/A
9/30/2023333,53311,29686,70889,216N/A
6/30/2023387,31623,26470,03971,318N/A
3/31/2023428,02033,61522,98124,777N/A
12/31/2022422,41929,84670,09171,545N/A
9/30/2022456,06942,564-10,348-9,225N/A
6/30/2022417,64037,235-18,804-17,659N/A
3/31/2022355,50225,320-4,436-3,707N/A
12/31/2021319,51423,199-60,566-59,711N/A
9/30/2021232,26012,52112,29113,108N/A
6/30/2021233,1047,31646,94247,683N/A
3/31/2021257,17510,9318,18410,203N/A
12/31/2020269,10110,91121,05227,784N/A
9/30/2020291,00115,281-6,1155,893N/A
6/30/2020299,74519,695-54,583-22,744N/A
3/31/2020306,62020,92125,26961,552N/A
12/31/2019318,85823,21331,87676,036N/A
9/30/2019311,18922,3952,42250,809N/A
6/30/2019285,51820,7879,55542,385N/A
3/31/2019274,37719,802-29,805-2,413N/A
12/31/2018286,61019,502-50,753-32,567N/A
9/30/2018290,66219,195-74,835-65,643N/A
6/30/2018314,06022,717-5,015670N/A
3/31/2018305,46925,174N/A-1,278N/A
12/31/2017287,01325,089N/A1,907N/A
9/30/2017284,25129,070N/A61,982N/A
6/30/2017251,48225,535N/A18,270N/A
3/31/2017215,81819,708N/A13,245N/A
12/31/2016180,38416,556N/A7,646N/A
9/30/2016156,31313,732N/A21,555N/A
6/30/2016134,55010,456N/A9,362N/A
3/31/2016126,1769,695N/A15,137N/A
12/31/2015125,51410,038N/A13,612N/A
9/30/2015120,1437,005N/A-12,671N/A
6/30/2015114,4164,874N/A-375N/A
3/31/2015131,0548,178N/A8,883N/A
12/31/2014121,1535,219N/A15,876N/A
9/30/2014107,7224,812N/A8,587N/A
6/30/2014104,9726,528N/A2,633N/A
3/31/2014103,8164,754N/A3,518N/A
12/31/201399,7014,503N/A6,488N/A
9/30/201387,0283,119N/A57N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de A039440 ( 39.2% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de A039440 ( 39.2% par an) devraient croître plus rapidement que le marché KR ( 28.3% par an).

Croissance élevée des bénéfices: Les bénéfices de A039440 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de A039440 ( 25.3% par an) devrait croître plus rapidement que le marché KR ( 10.6% par an).

Croissance élevée des revenus: Le chiffre d'affaires de A039440 ( 25.3% par an) devrait croître plus rapidement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de A039440 devrait être élevé dans 3 ans ( 23.3 %)


Découvrir les entreprises en croissance